Trial intelligence / Profile preview

Gemcabene effect on Simvastatin PK in healthy volunteers

NCT02587390Phase 1Completed

Sponsor
NeuroBo Pharmaceuticals
Start
May 2000
Primary completion
Jul 2000
Modality
Small Molecules
01

Overview

Phase 1, open-label trial of gemcabene in hypercholesterolemia (2 arms), sponsored by NeuroBo Pharmaceuticals. Primary endpoint: Pharmacokinetics at 15 days. Started May 2000; status: completed.

02

Drugs

gemcabene
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT02587390.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02587390.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call